| Zhang, Ju |
NCT06769919: A Randomized Controlled Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined with Systemic Therapy for Early-stage Breast Cancer |
|
|
| Not yet recruiting | 2/3 | 340 | RoW | Neoadjuvant radiotherapy | Xijing Hospital | Breast Cancer | 12/26 | 12/31 | | |
NCT03348293: Safety Study of 3D Printing Personalized Biodegradable Implant for Breast Reconstruction |
|
|
| Recruiting | 1 | 30 | RoW | 3D printing | Xijing Hospital | Breast Reconstruction, Breast Cancer | 12/19 | 12/25 | | |
| Cao, Yang |
| Recruiting | 3 | 400 | RoW | Tonifying Spleen and Kidney Sequential Regimen, TSKSR, Placebo of 'Tonifying Spleen and Kidney Sequential Regimen, Placebo of TSKSR | Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing University of Chinese Medicine, Peking University Third Hospital, Beijing Chao Yang Hospital, Jiangsu Province Hospital of Traditional Chinese Medicine, Shanghai Zhongshan Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine, Tianjin Union Medical Center, Henan Provincial People's Hospital, Zhengzhou Hospital of Traditional Chinese Medicine, Peking University Cancer Hospital & Institute, Chongqing University Cancer Hospital, Civil Aviation General Hospital | Colon Cancer | 05/21 | 05/21 | | |
NCT03384225: CBA Versus FBA Conditioning Followed by Haploidentical Allogeneic HSCT in Treatment of High Risk and Refractory AML |
|
|
| Recruiting | 3 | 120 | RoW | Cladribine, chlorodeoxyadenosine, Fludarabine, Busulfan, busulphan, Cytarabine, cytosine arabinoside | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Changhai Hospital, Xiangya Hospital of Central South University, Tongji Hospital, Wuhan Union Hospital, China, Chengdu PLA General Hospital, Tang-Du Hospital, Fujian Medical University Union Hospital | High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation | 07/22 | 07/22 | | |
NCT03384212: CBA Versus FBA Conditioning Followed by Allogeneic HSCT in Treatment of High Risk and Refractory AML |
|
|
| Recruiting | 3 | 120 | RoW | Cladribine, chlorodeoxyadenosine, Fludarabine, Busulfan, busulphan, Cytarabine, cytosine arabinoside | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Changhai Hospital, Xiangya Hospital of Central South University, Tongji Hospital, Wuhan Union Hospital, China, Chengdu PLA General Hospital, Tang-Du Hospital, Fujian Medical University Union Hospital | High Risk Acute Myeloid Leukemia, Allogeneic Hematopoeitic Stem Cell Transplantation | 07/22 | 07/22 | | |
NCT06294678: Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies |
|
|
| Recruiting | 3 | 198 | RoW | Time of stem cell infusion | Anhui Provincial Hospital | Acute Graft-versus-host Disease | 11/25 | 08/26 | | |
NCT05334823: A Study of pCAR-19B in the Treatment of CD19-positive Relapsed/Refractory B-ALL in Children and Adolescents |
|
|
| Recruiting | 2 | 100 | RoW | pCAR-19B cells | Chongqing Precision Biotech Co., Ltd | Acute Lymphoblastic Leukemia, Relapsed Pediatric ALL, Refractory Acute Lymphoblastic Leukemia | 12/24 | 07/25 | | |
NCT06449586: CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT |
|
|
| Recruiting | N/A | 250 | RoW | Letermovir | Ruijin Hospital | Hematologic Malignancy | 06/25 | 06/26 | | |
NCT06704542: Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation |
|
|
| Not yet recruiting | N/A | 1000 | RoW | | Ruijin Hospital | ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Diabetes Mellitus, Impaired Fasting Glucose | 04/25 | 04/25 | | |
